Type 2 diabetes Trials in Pembroke Pines, United States
Conditions / Type 2 diabetes / Pembroke Pines, United States
Type 2 diabetes is a medical condition with active clinical research programs worldwide.
26 total trials for this combination
Showing top 10 of 26 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06221969 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor | COMPLETED | — |
| NCT01195662 | A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication | COMPLETED | PHASE3 |
| NCT01455857 | A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT06037252 | A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00143520 | Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes | COMPLETED | PHASE2/PHASE3 |
| NCT02019264 | A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors | COMPLETED | PHASE4 |
| NCT00654745 | 18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics | COMPLETED | PHASE4 |
| NCT07220759 | Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide | ACTIVE_NOT_RECRUITING | — |
| NCT01609582 | Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease | TERMINATED | PHASE3 |
| NCT01606007 | Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |